Abstract:Objective: Maintaining a constant core body temperature is essential to homeothermic vertebrate survival. Adaptive thermogenesis in brown adipose tissue and skeletal muscle is the primary mechanism of adjustment to an external stimulus such as cold exposure. Recently, several reports have revealed that the liver can play a role as a metabolic hub during adaptive thermogenesis. In this study, we suggest that the liver plays a novel role in secreting thermogenic factors in adaptive thermogenesis. Bone morphogenetic protein 9 (BMP9) is a hepatokine that regulates many biological processes, including osteogenesis, chondrogenesis, hematopoiesis, and angiogenesis. Previously, BMP9 was suggested to affect preadipocyte proliferation and differentiation. However, the conditions and mechanisms underlying hepatic expression and secretion and adipose tissue browning of BMP9 remain largely unknown. In this study, we investigated the physiological conditions for secretion and the regulatory mechanism of hepatic Bmp9 expression and the molecular mechanism by which BMP9 induces thermogenic gene program activation in adipose tissue. Here, we also present the pharmacological effects of BMP9 on a high-fat-induced obese mouse model. Methods: To investigate the adaptive thermogenic role of BMP9 in vivo, we challenged mice with cold temperature exposure for 3 weeks and then examined the BMP9 plasma concentration and hepatic expression level. The cellular mechanism of hepatic Bmp9 expression under cold exposure was explored through promoter analysis. To identify the role of BMP9 in the differentiation of brown and beige adipocytes, we treated pluripotent stem cells and inguinal white adipose tissue (iWAT)-derived stromal-vascular (SV) cells with BMP9, and brown adipogenesis was monitored by examining thermogenic gene expression and signaling pathways. Furthermore, to evaluate the effect of BMP9 on diet-induced obesity, changes in body composition and glucose tolerance were analyzed in mice administered recombinant BMP9 (rBMP9) for 8 weeks. Results: Hepatic Bmp9 expression and plasma levels in mice were significantly increased after 3 weeks of cold exposure. Bmp9 mRNA expression in the liver was regulated by transcriptional activation induced by cAMP response-element binding protein (CREB) and CREB-binding protein (CBP) on the Bmp9 promoter. Treatment with BMP9 promoted the differentiation of multipotent stem cells and iWAT-derived SV cells into beige adipocytes, as indicated by the increased expression of brown adipocyte and mitochondrial biogenesis markers. Notably, activation of the mothers against decapentaplegic homolog 1 (Smad1) and p44/p42 mitogen-activated protein kinase (MAPK) pathways was required for the induction of uncoupling protein 1 (UCP1) and peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC1α) expression in BMP9-induced differentiation of SVs into beige adipocytes. The administration of rBMP9 in vivo also induced browning markers in white adipose tissue. In high-fat diet-induced obese mice, rBMP9 administration conferred protection against obesity and enhanced glucose tolerance. Conclusions: BMP9 is a hepatokine regulated by cold-activated CREB and CBP and enhances glucose and fat metabolism by promoting the activation of the thermogenic gene program in adipocytes. These data implicate BMP9 as a potential pharmacological tool for protecting against obesity and type 2 diabetes.

Bmp8a deletion leads to obesity through regulation of lipid metabolism and adipocyte differentiation

Spatial and temporal expression of bmp8a and its role in regulation of lipid metabolism in zebrafish Danio rerio

Inhibition of Notch Signaling Promotes Browning of White Adipose Tissue and Ameliorates Obesity.

BMP8B Activates Both SMAD2/3 and NF-κB Signals to Inhibit the Differentiation of 3T3-L1 Preadipocytes into Mature Adipocytes

Obesity Induces Resistance to Central Action of BMP8B Through a Mechanism Involving the BBSome

Bone Morphogenetic Protein 4 (BMP4) Alleviates Hepatic Steatosis by Increasing Hepatic Lipid Turnover and Inhibiting the Mtorc1 Signaling Axis in Hepatocytes

Bmp8a is an essential positive regulator of antiviral immunity in zebrafish

The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice

BAF60a Deficiency in Macrophage Promotes Diet-Induced Obesity and Metabolic Inflammation

Identification of BMP and Activin Membrane-Bound Inhibitor (BAMBI) As a Potent Negative Regulator of Adipogenesis and Modulator of Autocrine/paracrine Adipogenic Factors.

Adipose-Specific Bmp And Activin Membrane-Bound Inhibitor (Bambi) Deletion Promotes Adipogenesis By Accelerating Ros Production

BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis

CRISPR-mediated BMP9 Ablation Promotes Liver Steatosis Via the Down-Regulation of PPARα Expression

Role of Bone Morphogenetic Protein 4 in the Differentiation of Brown Fat-Like Adipocytes.

BMP4 Cross-talks with Estrogen/ERα Signaling to Regulate Adiposity and Glucose Metabolism in Females

Zinc Finger Protein ZNF638 Regulates Triglyceride Metabolism Via ANGPTL8 in an Estrogen Dependent Manner.

Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure

BMP4 Facilitates Beige Fat Biogenesis Via Regulating Adipose Tissue Macrophages.

BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice

Regulation of adipose tissue development and energy metabolism by VEGFB isoforms

BMPR2 Promotes Fatty Acid Oxidation and Protects White Adipocytes from Cell Death in Mice